World Cup legend Sir Geoff Hurst, MBE, backed by leading doctors, MPs and patient groups today appealed for all men with prostate cancer to get access to the best care as it emerged 7 out of 10 with advanced disease do not receive chemotherapy despite being eligible for treatment.1 Senior cancer specialists warned that while some men may have been offered chemotherapy and turned it down, others may never have been given the option at all, and so many patients are currently not being offered the

Yes there is a grant for this research of around 3 million. Cyanobacteria samples (the imagepond scum) will be collected and grown. Blue green algae is being studied as a potential alternative to some chemotherapy treatments. Once more breaking down the elements with biotech research.

Despite a price which can reach $100,000 a year, Avastin has become one of the most popular cancer drugs in the world. In 2007, sales of the drug reached $3.5 billion, with $2.3 billion in the United States.

But studies show the drug prolongs life by only a few months, if that. And some newer studies suggest the drug might be less effective against cancer than the FDA believed when the drug was approved.

Avastin also has serious, if infrequent, side effects, some of which can be lethal. And because it is almost always used with standard chemotherapy, patients on Avastin do not escape chemotherapy’s side effects, either.

If Avastin were inexpensive, or if truly held cancer at bay, few might care. But Avastin raises troubling questions. What does it mean to say the drug works? Is slowing the growth of tumors enough if life is not significantly prolonged or improved? How much evidence should there be before billions of dollars are spent on a drug? And when should cost be factored into the equation?

Some in the pharmaceutical industry believe that the price of Avastin will raise concerns about whether drugs are worth it, leading to a backlash like price controls or restrictions on use.

World Cup legend Sir Geoff Hurst, MBE, backed by leading doctors, MPs and patient groups today appealed for all men with prostate cancer to get access to the best care as it emerged 7 out of 10 with advanced disease do not receive chemotherapy despite being eligible for treatment.

An Oregon man given less than a year to live experienced a complete remission of advanced melanoma following a treatment that boosted his immune system to fight the tumors.

Melanoma is a cancer of the skin cells that produce tanning pigments. When caught early, melanomas can be easily treated by surgically removing the cancerous patch of skin. But advanced melanoma is often deadly.

About 20 years ago, scientists discovered that immune cells could latch onto and attack skin cancers. For this treatment, researchers drew blood from the patient, extracted special helper immune cells and then grew more of them in the laboratory. They then infused a massive dose of the newly grown cells back into the patient, without using chemotherapy or the other harsh drugs.